Appili Raises $3.1M Funding Round

Appili Therapeutics Inc., an anti-infective drug development company, has raised a $3.1 million round of equity financing, which will help pay for clinical trials due to start within 10 weeks.
The Halifax-based company said the money was raised through a private placement with new and current investors. There was only one investor that chose to be named – Innovacorp, which contributed to